Independent Wellness serves patients in multiple states across the U.S
The bottom line: GLP-1 microdosing represents a shift toward more personalized, patient-centered weight management
The search was conducted using the following search pattern: Acetylcysteine [Mesh] OR acetylcysteine [tiab] OR nacetylcysteine [tiab] OR n-acetyl cysteine [tiab]) OR NAC [tiab] AND ovulation [Mesh] OR total testosterone [tiab] OR progesterone [tiab] OR sexual function [tiab] OR impotence/erectile/dysfunction [tiab] OR sex hormone-binding globulin (SHBG) [tiab] AND Polycystic Ovary Syndrome [tiab] OR Ovary Syndrome [tiab] OR Polycystic Syndrome [tiab] OR Polycystic Ovary [tiab] OR Polycystic ovary disease [tiab] OR Stein-Leventhal Syndrome [tiab] OR Stein Leventhal Syndrome [tiab] OR Syndrome, Stein-Leventhal [tiab] OR Sclerocystic Ovarian Degeneration [tiab] OR Ovarian Degeneration, Sclerocystic [tiab]
In clinical trials, the dosage has started at 1 mg or 2 mg, then increased every 4 weeks until a maintenance dose of 4 mg, 9 mg, or 12 mg is reached
Inconsistent absorption from poor technique can create mini-spikes in drug levels that provoke GI reactions
It mimics a natural hormone your body produces to regulate appetite, digestion, and blood sugar originally developed for diabetes management but now clinically established for weight loss within supervised medical programmes